CBG Benefits

The CBG Benefits Blog

American Health Care Act Update – ACA Replacement Bill Withdrawn


UPDATE: On May 4, 2017, the the U.S. House of Representatives passed the American Health Care Act. Click here to read more.


All clients of CBG Benefits may login to the CBGconnect portal to download our Compliance Bulletin about the ACA Replacement Bills being withdrawn.On March 24, 2017, Republican leadership in the U.S. House of Representatives withdrew the American Health Care Act — their proposed legislation to repeal and replace the Affordable Care Act (ACA).

House Republicans could not secure enough votes to approve the legislation, which was scheduled to be voted on that day. As a result, the vote was canceled.

Employers must continue to comply with all applicable ACA provisions. We encourage you to download a copy of our 2017 ACA Compliance Checklist for an overview of compliance requirements that you may need to address in the months to come.

Additional Commentary

The team at Mintz Levin has published their viewpoints on the potential short-term and long-term impact on employers as a result of this Act being withdrawn. This includes:

  • Renewed attention on complying with ACA regulations that some employers anticipated would be going away
  • Stemming the anticipated tide of new state “play or pay” laws (including Massachusetts)
  • Avoiding upward pressure on employer premiums as a result of Medicaid reforms
  • Dealing with continued uncertainty as to what the future holds for the ACA and potential replacement bills

Click here to read the article from Mintz Levin >>

Support from CBG Benefits

Our team will continue to monitor for future developments. If you have any questions in the meantime as to how this impacts your business, please contact us at 781-759-1222.

In addition, if you need help understanding or meeting your compliance requirements under the ACA, please reach out to one of our ACA specialists.

Pin It    

Posted in: Benefits and Insurance, Human Resources, Legislation

Leave a Comment: (0) →